BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxycycline
,
rs2230926
,
VEGFA
,
Angiogenesis
,
Influenza
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ornithine decarboxylase inhibitor activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Cecum
Mammary gland
Skin
Nipple cross-section
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Injury of eye region
Antiphospholipid syndrome
Pyloric ulcer
Disorder of cornea
T-cell lymphoma
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
shogaol
C646
JW55
SYK inhibitor
A 769662
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MAST4
CCDC170
GOLT1B
KCNA1
OXA1L
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Time course of the mouse lacrimal gland after acute corneal trauma
L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP Breast cancer MCF7 cells with gene overexpression perturbations
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for ornithine decarboxylase inhibitor activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High G…
TArgeting Type 1 Diabetes Using POLyamines (TADPOL)
Topical Eflornithine for Pseudofolliculitis Barbae: RCT
Selenium for Prevention of Adenomatous Colorectal Polyps
Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Ade…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ